Clinical Trial Update: A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

View source ↗

Summary

A study is being conducted in Korea to learn more about the use and safety of Prevnar 20 (pneumococcal 20-valent conjugate vaccine) in the market, with particip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 20 (20-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Immunization, Safety | Status: RECRUITING